Literature DB >> 10720835

Rubber band ligation of symptomatic internal hemorrhoids: results of 500 cases.

V A Komborozos1, G J Skrekas, C A Pissiotis.   

Abstract

BACKGROUND/AIM: In this prospective study the results of rubber band ligation (RBL) of symptomatic hemorrhoids in 500 consecutive patients with 2nd (255 cases), 3rd (218 cases) and 4th degree (27 cases) hemorrhoids are presented.
METHODS: The patients' symptoms were hemorrhage in 142 cases (28.4%), prolapse in 33 cases (6.6%) and both hemorrhage and prolapse in 325 cases (65%). Sixteen patients with hemorrhoids had liver cirrhosis and portal hypertension. RBL was performed using the St Marks' applicator (Seward) on an outpatient basis. Multiple ligations in two (259 cases) or three (190 cases) sessions were undertaken in 449 patients (89.8%), while a single ligation was done in 51 cases (10.2%).
RESULTS: Successful results were achieved in 440 cases (88%) in a 24-month follow-up. A total of 94 patients (18.8%) had complications which required no hospitalization. Pain and hemorrhage were the most frequent complications. RBL proved to be safe in 16 patients with coagulation disorders due to liver cirrhosis. Two years after RBL, symptomatic recurrence was 11.9% (53/445) with repeat RBL or surgery in 9.2% (41/445).
CONCLUSIONS: RBL is a useful, safe and successful method for treating symptomatic 2nd and 3rd degree hemorrhoids, which can be applied successfully in selected cases with 4th degree hemorrhoids, but with an increased rate of recurrence and additional treatment requirements. Also, RBL seems to be safe in patients with liver cirrhosis and portal hypertension. Copyright 2000 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2000        PMID: 10720835     DOI: 10.1159/000018803

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  12 in total

1.  Sutureless closed hemorrhoidectomy: a new technique.

Authors:  J Sayfan; A Becker; L Koltun
Journal:  Ann Surg       Date:  2001-07       Impact factor: 12.969

2.  Rubber band ligation of symptomatic hemorrhoids: an old solution to an everyday problem.

Authors:  Vasileios Komporozos; Vasiliki Ziozia; Aikaterini Komporozou; George Stravodimos; Ageliki Kolinioti; Antonia Papazoglou
Journal:  Int J Colorectal Dis       Date:  2021-03-10       Impact factor: 2.571

3.  [Therapy of hemorrhoidal disease].

Authors:  A Herold
Journal:  Chirurg       Date:  2006-08       Impact factor: 0.955

Review 4.  The Evaluation and Office Management of Hemorrhoids for the Gastroenterologist.

Authors:  Mitchel Guttenplan
Journal:  Curr Gastroenterol Rep       Date:  2017-07

5.  Rubber Band Ligation for Hemorrhoids: an Office Experience.

Authors:  Fahmi Omer Aram
Journal:  Indian J Surg       Date:  2015-10-22       Impact factor: 0.656

6.  Long-term result after rubber band ligation for haemorrhoids.

Authors:  Antonio Forlini; Antonio Manzelli; Silvia Quaresima; Massimo Forlini
Journal:  Int J Colorectal Dis       Date:  2009-04-23       Impact factor: 2.571

7.  Rubber band ligation for 750 cases of symptomatic hemorrhoids out of 2200 cases.

Authors:  Ayman-M El Nakeeb; Amir-A Fikry; Waleed-H Omar; Elyamani-M Fouda; Tito-A El Metwally; Hosam-E Ghazy; Sabry-A Badr; Mohmed-Y Abu Elkhar; Salih-M Elawady; Hisham-H Abd Elmoniam; Waiel-W Khafagy; Mosaad-M Morshed; Ramadan-E El Lithy; Mohamed-E Farid
Journal:  World J Gastroenterol       Date:  2008-11-14       Impact factor: 5.742

Review 8.  [Stage-adjusted treatment for haemorrhoidal disease].

Authors:  A Herold
Journal:  Chirurg       Date:  2008-05       Impact factor: 0.955

9.  A novel device reduces anal pain after rubber band ligation: a randomized controlled trial.

Authors:  T J Lam; R J F Felt-Bersma
Journal:  Tech Coloproctol       Date:  2012-04-12       Impact factor: 3.781

10.  The HubBLe trial: haemorrhoidal artery ligation (HAL) versus rubber band ligation (RBL) for haemorrhoids.

Authors:  Jim Tiernan; Daniel Hind; Angus Watson; Allan J Wailoo; Michael Bradburn; Neil Shephard; Katie Biggs; Steven Brown
Journal:  BMC Gastroenterol       Date:  2012-10-25       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.